1. Introduction {#s0005}
===============

Chronic pain is a major health problem with a large impact on the emotional, physical and social functioning of persons as well as society. An estimation of 10--30% adults suffer from chronic pain ([@bb0255]). Empirical support has been found for cognitive behavioural therapy (CBT) and acceptance and commitment therapy (ACT), which is a form of CBT, for a variety of chronic pain problems compared to wait-list controls and alternative active treatments ([@bb0145], [@bb0165]). Unfortunately, the availability of CBT and ACT for chronic pain is poor for many individuals suffering from chronic pain. It is essential to increase the accessibility of evidence-based treatments such as CBT to chronic pain suffers. For the last decade researchers across the world have investigated the power of the internet to create internet-based prevention and treatment programmes ([@bb0010], [@bb0005]). Different methods are used to administer the interventions and to encourage the participants. Guided internet-based programmes provide instructions for behavioural change to the participants while being monitored by a therapist. In contrast, unguided internet-based interventions are websites that are fully automated. Furthermore, there are a great number of apps (downloadable programmes designed to run on the smart phone) relating to pain, but there is no regulatory body evaluating and approving the release of health-care apps ([@bb0260]).

Several systematic reviews have been performed the last five years, more specific 2010, 2012 and 2014, indicating the rapid development in this area. In a review conducted by [@bb0235], 11 studies were assessed to quantify the efficacy of internet-based CBT (iCBT) for chronic pain. The studies included were randomized controlled trials. The main outcome used in the meta-analysis was pain, and results showed small reductions in pain compared to waiting-list control groups. High dropout rates were reported with an average of 26%, which is higher than in traditional CBT interventions (14%). In another review ([@bb0035]) 17 articles that evaluated iCBT for chronic pain were included. The total sample analysed consisted of 2503 individuals with different chronic pain syndromes including headache, back pain, musculoskeletal pain, abdominal pain and fibromyalgia. Results showed that iCBT was associated with improvements in pain, activity limitation, and costs associated with treatment. The effects on depression and anxiety were less consistent. A more recent review included fifteen studies with a total sample of 2012 adults with chronic pain. The researchers found positive effects regarding pain intensity, disability, depression and anxiety at post-treatment. It was found that there is insufficient evidence to make conclusions regarding the efficacy of internet-based psychological treatments in participants with headache conditions ([@bb0150]).

The rapid increase of internet-based studies for chronic pain for adults and children/youth and the technical development and increasing trials for different pain diagnoses including headache motivate a review with a broader perspective on internet-based treatment. The present review aims to do an updated review with a broad inclusion of different chronic pain diagnoses and to include studies with children/youth with chronic pain. The more specific aims are to assess disability and pain and also outcomes of catastrophizing, depression and anxiety are of interest. Furthermore, risk of bias was assessed for the different trials and meta-analytic statistics were calculated for the different outcome variables.

2. Methods {#s0010}
==========

2.1. Identification of studies {#s0015}
------------------------------

This review includes published journal articles describing randomized controlled trials of internet-based CBT for chronic pain. Studies were identified using different sources. Existing systematic reviews in the field were used ([@bb0035], [@bb0150], [@bb0235]). Furthermore, a search of MEDLINE, PsychINFO, CINAHL and The Cochrane Library was conducted (1990 to March 2015). All searches were carried out on the 23rd of February and 5th of March 2015. Unpublished literature was not sought for the review.

The titles, abstracts and keyword were searched for the following terms: cognitive, cognitive behavioral therapy, CBT, acceptance, ACT, acceptance and commitment therapy, combined with chronic pain, fibromyalgia, FM, persistent pain, back pain, CLBP, musculoskeletal pain, rheumatoid arthritis, chronic headache, headache, and persistent headache and further combined with internet, online, self-help, web-based and also combined with control trial, RCT, and control trial. The aim was to capture efficiently the maximum number of published trials in the field.

2.2. Study selection {#s0020}
--------------------

Study selection was carried out by the first author and agreed by the other authors. [Fig. 1](#f0005){ref-type="fig"} shows a flow diagram of the study selection process for the review. Inclusion criteria adopted was: 1) randomized controlled trial; 2) article written in English; 3) web-based or mobile phone intervention for the treatment of chronic pain of different types; 4) measurement of disability level and/or pain; 6) treatments that were based on CBT- or ACT principles; and 7) a comparison between an intervention group and a waiting-list control or other treatment. The search yielded a total of 891 articles. When the duplicated articles and the ones that did not fulfill the inclusion criteria were removed, 32 remained. After the full text selection ten articles were excluded since they did not fulfill the inclusion criteria; two were not randomized controlled trials ([@bb0195], [@bb0220]); two studies included samples with pain but not chronic pain ([@bb0135], [@bb0190]); two trials were not CBT-based interventions but peer support ([@bb0230], [@bb0225]); on study did not include a web-based intervention only telephone administered behavioral treatment ([@bb0115]); one trial ([@bb0160]) included a sample reported in an study already included ([@bb0250]) and two were study protocols ([@bb0170], [@bb0210]) leaving 22 articles that were included. For further information see [Fig. 1](#f0005){ref-type="fig"}.Fig. 1Flow chart.

2.3. Data extraction {#s0025}
--------------------

The first and last authors reviewed independently the full text of articles meeting the eligibility criteria. Data were extracted by the first author and reviewed and agreed by the last one. Data extracted included details of participants\' pain condition, sample size, design characteristics, outcome measures, information about the intervention, mean age of participants, educational level of the participants, pain duration, percentage of women, method of treatment delivery, period of treatment, the type of control condition used for comparison, the participants\' attrition rate and the results of the outcomes. Primary and secondary outcome information was extracted.

2.4. Data management {#s0030}
--------------------

The time point for the collection of data was direct after the intervention. Furthermore, the studies\' methodological quality was assessed by the reviewers using an adapted Cochrane Collaboration tool for the risk of bias within randomized trials ([@bb0185]).

We relied primarily on guidelines for application of the Cochrane Collaboration tool to assess five areas of potential bias: selection bias, detection bias, attrition bias, reporting bias and other sources of bias. Performance bias was removed since it is difficult to conceal CBT-based treatment from the participants or the therapist. The different areas of potential bias are described in the [Results](#s0035){ref-type="sec"} section.

We used the program Comprehensive Meta-Analysis (version 2.2.021; CMA) to calculate pooled mean effect sizes using random effects models. We also calculated the I^2^-statistic as an indicator of heterogeneity in percentages (with 0% indicating no observed heterogeneity, 25% low, 50% moderate, and 75% high heterogeneity). Publication bias was tested by inspecting funnel plots and Egger\'s test ([@bb0155]), using the procedures implemented in CMA.

3. Results {#s0035}
==========

3.1. Study characteristics {#s0040}
--------------------------

[Table 1](#t0005){ref-type="table"} shows the characteristics of the included studies. A total of 2354 persons with chronic pain were randomized to internet-based interventions across the 22 trials. The sample sizes ranged from 44 to 305. Most trials were conducted in USA (n = 9, 40.9%) and Sweden (n = 9, 40.9%), followed by the Netherlands (n = 2, 9.0%), Australia (n = 1, 4.5%) and Norway (n = 1, 4.5%). Two of the included studies involved children/youth with chronic pain ([@bb0180], [@bb0250]). The mean age across studies ranged from 36.7 to 65.8 years old, excluding the children/youth trials. The majority of the participants were females; the percentage ranged from 52.1--95%. One study only included women ([@bb0200]). In the trials including adults the education level was defined in different ways but in 54.5% (n = 12) of the studies, the majority of the participants had some level of higher education level. In the articles where the education level was lower (n = 3) the recruitment was from clinical settings ([@bb0080], [@bb0090], [@bb0120]). In one study the participants with university education were as many as those with non-university degree ([@bb0125]). Four trials lacked information about education levels ([@bb0020], [@bb0045], [@bb0140], [@bb0275]).Table 1Study characteristics.Study/countryHealth conditionWomen (%)Age group (age range)Study groupsN recruitment methodControl conditionIntervention[a](#tf0005){ref-type="table-fn"}GuidancePeriod of treatmentEducation levelPain duration[@bb0020]\
SwedenHeadache81.8% (n = 36)40.3 (range: 18--59)Adults44 (advertisement)Web-based treatment with telephone support or web-based onlyCBTYes (psychologists)6 weeksNo informationHeadache duration: 05--1 year: n = 2\
1--5 years: n = 14\
6--10: n = 5\
 \> 10: n = 23[@bb0040]\
USAMixed chronic pain conditions87.2% females in total sample (n = 78)\
87,8% in intervention group (n = 41) and 86,5% in WLC (n = 37)65,8 years (range: 55--91)Older adults78 (through public service)Intervention or WLCCBT and mind--body intervention, 6 weeks.Yes (research assistant)6 weeks38.5% college graduation, 29.5 some college, 23.1% graduated school.No information[@bb0045],\
SwedenChronic pain and burnout89.1%\
(n = 49)Treatment group: 47 (sd = 8; range 32--62 years)\
WLC: 47 (sd = 6; range 34--61)Adults55 (advertisement)Intervention or WLCCBTYes (researcher and an expert patient)20 weeksNo informationNo information[@bb0050]\
USAChronic migraine89% (n = 165) femalesMean age = 42.6 (sd = 11.5) (range 20--66)Adults189 (advertisement)Intervention or TAUCBTNO (only reminders)4 weeks\< 11th grade: 0.56% (n = 1)\
High school or general education diploma: 17.22% (n = 31)\
2 years of college/AA degree/technical school training: 22.22% (n = 40)\
College graduate (BA or BS): 33.89% (n = 61)\
Master\'s degree: 20% (n = 36)\
Doctoral/medical/law degree: 11% (n = 6.11)Average baseline headache duration: 2.47 h per day (sd = 1.44)[@bb0080]\
SwedenMixed chronic pain conditions72.2% (52)40.1 (sd = 8.94)Adults72 (clinical setting)Intervention or active control group (moderated online discussion forum)CBTYes (graduate students)8 weeksUniversity education: 33.3% (n = 24); upper secondary school: 54.1% (n = 39) and nine-year compulsory school: 12.5% (n = 9)Pain duration in years M (SD):6.2 (2.07)[@bb0090]\
SwedenMixed chronic pain condition59.2%(45)49.1 (sd = 10.34)Adults76 (clinical setting)Intervention or active control group (moderated online discussion forum)ACTYes (graduate students)7 weeksUniversity education: 43.4% (n = 33); upper secondary school: 47.4% (n = 36) and nine-year compulsory school: 9.2% (n = 7)Pain duration in years M (SD):15.3 (11.65)[@bb0100]\
SwedenMixed chronic pain conditions85%(44)50.69 (sd = 12.72)Adults52 (clinical setting)Intervention or active control group (moderated online discussion forum)CBTYes (graduate students)8 weeksNine-Year compulsory school: 19% (n = 10)\
Upper secondary school: 23% (n = 12)\
University education \< 2 years: 6% (n = 3)\
University education \> 2 years: 52% (27)3 months-5 year: 33% (n = 17)\
5--10 years: 13% (n = 7)\
10 years and more: 54% (n = 28)[@bb0055]\
SwedenBack pain62.5% (35)44.6 (sd = 10.4)Adults56 (advertisement)Intervention or WLCCBT with some physical componentsYes, (graduate students) with weekly structured telephone calls6 weeksUniversity education: 57.1% (n = 32); upper secondary school: 25% (n = 14) and nine-year compulsory school: 17.9% (n = 10)Pain duration in years M (SD):10.1 (9.2)[@bb0060]\
SwedenBack pain68.5% (37)43.2 (sd = 9.8)Adults54 (advertisement)Intervention or WLCCBTYes (clinical psychologists), contacted once by telephone8 weeksUniversity education: 53.7% (n = 29); upper secondary school: 40.7% (n = 22)and nine-year compulsory school: 5.6% (n = 3)Pain duration in years M (SD):12.1 (8.5)[@bb0105]\
USAChronic lower back pain83%42.5 (21--74) (sd = 10.3)Adults141 (advertisement)Intervention or WLCCBTNo (only reminders)3 weeks54% no more than 2 years of college or technical school6-516 months\
(M = 103.7, SD = 94.1)[@bb0110]\
USABack pain67%46.14 (sd = 11.99; range = 18--79))Adults209 (through advertisement through professional, patient contacts the American chronic pain association website)Intervention or active control condition that received text-based materialCBTNo4 weeks\< 11th grade: 2(1.01)\
HS^1^ or GED^2^: 50 (25.25)\
Partial college/AA:63 (31.82)\
BA or BS: 55 (27.78)\
Master\'s: 26 (13.13)\
PhD/MD: 2 (1.01)\
\
1 = High school\
2 = General Educational Development DiplomaNo information[@bb0120]\
The NetherlandsMixed chronic painFemales n = 32 (64%) (internet n = 15, 68,2%; face-to-face n = 17, 60.7%)52.1 (sd = 11.2)AdultsRandomized n = 72, started the program n = 50 (clinical setting)Internet intervention vs face-to-face group interventionCBT 7 weeks + 1 week two months after the last module.Yes (trained psychologist).7 weeks + 1 weekTertiary education n = 10, 20%; higher secondary education n = 20, 40%; lower secondary education n = 18, 36% and primary education n = 2, 7.1%.Mean (sd): 102 (98.4) in months. Range 8--365.\
Internet: 1182 (121.7) Range: 8--365\
Group: 90.0 (77.1) Range 12--300-[@bb0125]\
AustraliaMixed chronic pain conditions85% (n = 53)49 (20--91)Adults63 (advertisement)Intervention or WLCCBTYes, (clinical psychologist with postgraduate qualification)8 weeksUniversity education 40% (n = 25)\
Certificate/diploma/other 40% (n = 25)M = 7.36(sd = 8.10)[@bb0140]\
USAChronic headache79.1% (= 110)Treatment: 43.6 (sd = 12.0); wlc: 41.0 (sd = 11.8); dropout 39.2 (sd = 14.7)Adults139 (through internet websites)Internet-based treatment or symptom monitoring waitlist controlCBTYes (researchers)4 weeksNo informationNo information[@bb0175]\
SwedenChronic migraine69.9% femalesGroup intervention + handmassage: mean = 49.4 (range 22--65); group intervention without handmassage mean = 44.8 (23--61) and control group mean = 49.0 (27--65)Adults83 (advertisement)Intervention MBT without hand-massage, intervention with hand-massage and control group\
\
3 armsCBT with multidisciplinary componentsNo11 months for the intervention groups, and 8 months for the control group.College/university/post-graduate studies: Intervention group with hand massage: 68%; intervention group without hand massage: 66.7% and control group: 48.1% Upper secondary school: 24,25,40.7% respectively. Nine year compulsory school/elementary 8, 8.3, 11,1% respectively.Migraine frequency during baseline recording: Group with hand massage: 10.1 (range 1--27), tension-type headache 32, Aura 48. Intervention group without hand-massage: mean = 13.9 (range 1--33); tension type headache: 41.7; aura 29.2. Control group: migraine mean: 10.0 (range 2--33); tension type: 37; aura: 51.9[@bb0180]\
USAPediatric recurrent pain63.8% (n = 30)11.7 (sd = 2.1)Youth (9--16 years old)47Intervention (internet-based treatment) or standard medical care waitlistCBTYes (researchers)7 weeks-Median duration of pain problem in years (minimum/maximum): 3.0 (0.25/11)[@bb0200]\
NorwayWomen with chronic widespread pain (CWP)100% femalesIntervention group (n = 69) 44.59 (sd = 11.13) and the control group n = 65\
43.80 (sd = 11.20)Women adults135 (clinical setting)Intervention or WLCCBT/ACT smartphone 4 weeksYes (therapist)4 weeks43.5% (n = 30) in the intervention group college/university and 34.8% (n = 23) in the control group. Total 39.26% (n = 53).\
High school 36.30% (n = 49). Elementary 15.56% (n = 21).In the treatment group M = 13.133 (sd = 8.78) and in the control group M = 15.47 (sd = 12.09)[@bb0250]\
USAMixed chronic pain\
conditions72.9%14.8 (sd = 2.0)Children and adolescents and their parent.48Intervention or WLCCBT and social learningYes (phd doctoral student)8 weeks for children and parents.Parents\' educational level 40.4% vocational school or some college; 34.0% college degree.No information[@bb0270]\
USAMixed chronic pain conditions64.3%\
(n = 196)44.93 (range: 19--78)Adults305 (information on pain sites)Online self-management program or wait list control with TAUCBTNo6 weeks10.5% high school degree; 70.8% reported attending at least some college, 18.4% had advance degrees89.5% reported having pain for more than 2 years[@bb0275]\
SwedenRecurrent headache67.6% (n = 69)36.7 (range: 19--62)Adults102 (advertisement)Intervention or WLCCBTYes (graduate students)6 weeksNo informationHeadache duration: 05-1 year: n = 5\
1--5 years: n = 41\
 \> 5: n = 52[@bb0280]\
The NetherlandsMixed chronic pain conditions75.3--76.8% on different conditions52.9 (ACT), 52.3 (EW)& 53.2 (WLC) (sd = 13.3, 11.8; 120)Adults238 (advertisement)3-conditions: Intervention; control condition expressive writing or WLCACTYes (graduate psychology students)9 modules which could be worked through in 9--12 weeks.High level of education 45.1% (ACT); 44.3 (EW) & 42.9 (WLC).Low 19.5 (ACT); 19.0 (EW); 22.1 (WLC).Duration \> 5 years:\
58.5--69.66%[@bb0300]\
USAFibromyalgia95% females50 years (sd = 11.5)Adults118\
(clinical setting)Standard care or experimental intervention consisted of standard care plus web-enhanced behavioral self-management program (WEB-SM)CBTNo6 months40% college training, 30% college degree, 12% processing education extending beyond college graduation and 18% being high school graduates or less.The average participant had held a diagnosis of FM for 9.4 year (sd = 6.5)[^1]

3.2. Health conditions {#s0045}
----------------------

Several studies (n = 9, 40.9%) targeted people with mixed chronic pain conditions ([@bb0040], [@bb0045], [@bb0100], [@bb0080], [@bb0090], [@bb0120], [@bb0125], [@bb0270], [@bb0280]) and two (9%) studies specifically included persons with fibromyalgia/widespread pain ([@bb0200], [@bb0300]). The two studies (9%) that included children and youth included mixed chronic pain problems ([@bb0180], [@bb0250]). Four trials involved individuals with back pain ([@bb0055], [@bb0060], [@bb0105], [@bb0110]). Five studies (22.7%) targeted persons with chronic headache and/or migraine ([@bb0020], [@bb0050], [@bb0140], [@bb0175], [@bb0275]).

3.3. Interventions and control conditions {#s0050}
-----------------------------------------

As seen in [Table 1](#t0005){ref-type="table"} all studies evaluated behavioral-based treatments. Most of the studies (n = 19, 86.36%) stated that the intervention was CBT-based ([@bb0020], [@bb0040], [@bb0045], [@bb0050], [@bb0060], [@bb0100], [@bb0055], [@bb0080], [@bb0105], [@bb0110], [@bb0120], [@bb0125], [@bb0140], [@bb0175], [@bb0180], [@bb0250], [@bb0270], [@bb0275], [@bb0300]) while two were ACT interventions ([@bb0090], [@bb0280]). One intervention ([@bb0200]) used an intervention based on both CBT and ACT. However, several interventions described ACT-influenced techniques such as mindfulness ([@bb0100], [@bb0060], [@bb0105]). Four interventions ([@bb0055], [@bb0080], [@bb0175], [@bb0200]) also included multidisciplinary components. The intervention period ranged from three weeks ([@bb0105]) to 11 months ([@bb0175]).

Control conditions varied; 14 (63.6%) trials used wait-list control conditions ([@bb0040], [@bb0045], [@bb0055], [@bb0060], [@bb0105], [@bb0125], [@bb0140], [@bb0170], [@bb0180], [@bb0275]) or active control conditions ([@bb0100], [@bb0080], [@bb0090], [@bb0110]). Three studies compared the experimental conditions with treatment as usual ([@bb0050], [@bb0270], [@bb0300]). One study used a face-to-face control condition ([@bb0120]), and two trials ([@bb0020], [@bb0200]) compared an internet-based intervention with telephone/smartphone support to an only internet-based treatment. In addition, one trial for individuals with chronic headache used three conditions; one consisted of an internet-based intervention, one of an internet-intervention and hand massage and the third condition was a wait-list-control ([@bb0175]). Another study for adults with mixed chronic pain diagnoses also allocated participants to one of three conditions: internet-based intervention, expressive writing condition and wait-list control ([@bb0280]).

3.4. Guidance {#s0055}
-------------

An important aspect of web-based interventions is how interactive they are, i.e. how much the participant participates within the program e.g. uses self-assessment and self-monitoring tools. All internet-based treatments require that participants act by themselves but the type and degree of feedback offered vary. The degree of feedback differs from self-guided programs that not offer supportive feedback or provides automated feedback to guided programs that offers tailored feedback ([@bb0015], [@bb0240]).

77.27% (n = 17) of the included trials were guided. In six ([@bb0100], [@bb0090], [@bb0055], [@bb0080], [@bb0275], [@bb0280]) of the studies the online therapists were graduate students who received supervision of clinical psychologists. In several trials (n = 4) the researchers were the therapists ([@bb0020], [@bb0140], [@bb0180], [@bb0200]). One trial was guided by a research assistant that also was a nurse ([@bb0040]). In another study, in addition to the researcher, an expert patient was used to guide the participants ([@bb0045]). In three trials the therapists consisted of clinical psychologists ([@bb0060], [@bb0120], [@bb0125]). In [@bb0250] the participants were guided by a Ph D psychology postdoctoral fellow.

3.5. Outcomes {#s0060}
-------------

Focus in the present review is post-intervention data. Seven (31.8%) ([@bb0020], [@bb0040], [@bb0060], [@bb0175], [@bb0270], [@bb0275], [@bb0300]) of the 22 trials did not include follow-up data. All the outcomes used in the different trials are presented in [Table 2](#t0010){ref-type="table"}.Table 2Outcomes and results in the included trials.TrialOutcome measuresFunctioning\
Pre-post (interaction effects when nothing else specified)Pain\
Pre-post (interaction effects when nothing else specified)Psychological/psychosocial variables\
Pre-post (interaction effects when nothing else specified)Follow-upDrop-out rate at post-treatment[@bb0020]No primary outcome defined.\
\
Outcome measures: Headache diary, HADS, PSS, HDI, CSQHDI: decreased significantly for both the sole internet intervention and the internet intervention with telephone support a main effect of time was found.Pain duration: Post-hoc test showed that the self-help plus telephone group had a significantly decreased duration. In the self-help plus telephone group, 29% reached a clinically significant improvement and in the self-help only group, 23%. The difference was however not statistically significantMain effect were found on the: HADS-depression subscale, PSS-stress scale, CSQ-reinterpreting pain sensations and CSQ-catastrophizing\
Interaction effects in favour of the internet group with telephone support were found on the subscales CSQ-ignore pain and CSQ-coping self-statements. Post hoc analyses confirmed the difference in CSQ-ignore pain.No FU31.9%[@bb0040]No primary outcomes defined.\
\
Outcome measures: BPI, PSEQ: PSEQ,; CES-D 10; STAI-6BPI: NSBPI-pain intensity: NS\
\
.PAQ (awareness of responses to pain): interaction effect was found.\
CES-D (depression): NS\
STAI: NS\
PSEQ (pain self-efficacy):NSNo FU12.0%[@bb0045]No primary outcome defined.\
\
Outcome measures:\
SF-36, HADS, a stress barometerSF-36- physical functional scale: NS However, thirteen of 23 individuals (57%) increased their work capacity. More individuals in the treatment group had increased their work capacity when compared to the waiting list group.SF-36- bodily pain.HADS-depression scale. In an intent-to-treat analysis, the NNT was calculated for anxiety and depression. The number needed to treat regarding recovering from anxiety and depression was 2. For increased work capacity, the number needed to treat was 31 year ([@bb9000])8.3%[@bb0050]No primary outcomes defined.\
\
Daily headache record; MIDAS; CPCI-42, HSES, PCS, Headache-specific locus of control, DASS-21, PGIC.Migraine-related disability: NSNo information.Interaction effects were found in the scales: PCS-helplessness scale, PCS-magnification scale:\
PCS-rumination scale, PCS-total scale, DASS-depression scale, DASS-stress scale; CPCI-exercise, CPCI-persistence, CPCI-relaxation, CPCI-social support and HSES-Self-efficacy.\
Post-hoc tests revealed that participants who used the website reported a significantly greater decrease in depression, as compared with the control condition.3 and 6 months follow-up16.4%[@bb0080]Primary outcome: CSQ\
\
Secondary outcomes: HADS, MPI, PAIRS; QOLIPAIRSMPI-Pain severity: NSInteraction effects were found in the scales: CSQ-diverting attention subscale; CSQ-catastrophizing scale; HADS-anxiety scale; HADS-depression scale; MPI-life control scale; MPI-affective distress scale and MPI-punishing responses scale6 months22.2%[@bb0090]Primary outcome: CPAQ\
\
Secondary outcomes: HADS, MPI, PAIRS, QOLIMPI- interferingMPI-Pain severity: NSInteraction effects were found in the scales: CPAQ-activity engagement scale;\
CPAQ- pain willingness scale; CPAQ-total scale; HADS-anxiety scale; HADS-depression scale: CSQ*-*catastrophizing subscale; CSQ-praying and hoping subscale; MPI-affective distress subscale.6 months19.7%[@bb0100]Primary outcomes; MADRS-S, BAI, PDI\
\
Secondary outcome measures: ASI, PCS, CPAQ, CSQ, MPI, QOLI.PDIMPI-Pain severity: NSInteraction effects were found in the scales: MADRS-S, BAI, CPAQ-activity engagement subscale. The difference was clinical significant for the completers.\
Significant effects were also found on the CSQ*-*catastrophizing subscale and PCS-total scale.1 year17.3%[@bb0055]Primary outcome: CSQ\
\
Secondary outcomes: MPI, HADS, PAIRS, Pain diary.MPI-Interference: NSMPI-Pain severity: NSInteraction effects were found in the scales: CSQ-catastrophizing; CSQ-control over pain and CSQ-ability to decrease pain. For the catastrophizing scale 39% (n = 10) showed a reliable improvement, and in the control group 14% (n = 4), a difference that was statistically significant.3 months8.0%[@bb0060]Primary outcome: CSQ\
\
Secondary outcomes: HADS, MPI, PAIRS; QOLIMPI-Interference: NSMPI-Pain severity: NSAn interaction effect was found in the CSQ-catastrophizing scale. A post hoc test on the pre to post change scores confirmed a difference between the groups at posttest. Reliable Change Index was calculated for catastrophizing scale in the CSQ, 58% (15/26) of the treated participants showed a reliable improvement, and in the control group 18% (5/28). This difference that was statistically significant.\
A significant interaction effect was also found in QOLI, and this was explained by a decrease in the control group and an increase of QOLI scores in the treatment group confirmed by a post hoc test.No Fu7.4%[@bb0105]Primary outcome:\
SOPA\
\
Secondary outcomes: PCS, RMDQ, FABQ, NMRS, SES.RMDQPain rating-average pain; pain rating---highest pain and pain rating---lowest pain: NSInteraction effect were found on: Pain Catastrophizing Scale (PCS); PCS-rumination; PCS-magnification; PCS-helplessness and negative mood regulation scale.6 weeks7.1%[@bb0110]No primary outcome defined.\
\
Outcome measures:\
BPI, ODQ, DASS, PGIC, CPCI-42, PCS, PSEQ, FABQ.ODQ: NSBPI-worst pain scale: participants recruited online in the internet-group showed a greater mean decrease from baseline to post-test while no significant difference were found for the participants recruited from the clinical settings. 12.3% in internet-group decreased in current pain comparing with 7% in the control condition.Website participants showed clinically significant reductions in DASS-depression; DASS-anxiety and DASS-stress.3 and 6 months7.5%[@bb0120]Primary outcome: PCS.\
\
Secondary outcomes:\
VAS-pain intensity, PCCL (5 subscales), RAND-36 (9 subscales).\
Additionally cost-effectiveness was assessed.VAS interference and fatigue: NS ITT and completers-analyses showed significant main effects on the subscales physical functioning, social functioning, pain and perceived health change.VAS-pain intensity: NS\
\
\
.Main effects for time on both the internet intervention and the live intervention were found on PCS (ITT-analyses) and PCCL.\
An interaction effect was found on PCS (Completers-analyses) in favour of the internet group.\
2 months20.6%[@bb0125]Primary outcomes: PHQ-9; GAD-7; RMDQ\
\
Secondary outcomes: WBPQ, pain intensity, PSEQ, TSK, PRSSRMDQ.An interpain (average pain)\
\
Clinical significance on all primary outcomes except average pain.Interaction effect were found on: PHQ-9 (depression); PSEQ (self-efficacy); TSK and PRSS (catastrophizing).3 months4.0%[@bb0140]No primary outcome defined.\
\
Outcome measures: Headache diary, HSQ, CES-D, STAI, HDI.A significant reduction was found on HDI.\
The total treated sample (N = 49) showed a significant reduction on medication index scores from baseline to post-treatment.Interaction effects were found on: Headache index and Headache Index within the aggregate treated sample. The percentage of treatment completers showing clinically significant improvement, defined as a 50% or greater reduction in Headache Index scores without a corresponding increase in overall medication consumption, was 38.5%. Article in pressCES-D (depression): NS\
STAI: NS2 months38.1%[@bb0175]No primary outcome defined.\
Outcome measures: PQ23, MADRS-S; diary of migraine frequency, physical activity lasting 30 min or more, and intake of migraine medications.No informationMigraine frequency: 50% greater, reduction was found in 40% and 42% participants of the two groups receiving MBT (with and without hand massage respectively) comparing to 15% in the control group. No significant difference in reduction of migraine was seen between the two treatment groups. Preliminary data indicate that migraine medication decreased in the intervention groups but not in the control group.MADRS-S: NS\
PQ23-Perceived work performance (8 months versus start): significant improvement in the intervention group MBT with hand massage.No FU8.4%[@bb0180]Primary outcome: Pain Index in pain diary, NRS\
Secondary outcome measures: PedsQL, VAS- how much they expected treatment to help them, VAS- evaluations of treatment and perceived benefit of treatment.No information.Significant effects were found on the Pain diary in both pain frequency and pain intensity at 1-month follow-up. The number of pain-free days increased significantly more in the treatment group than the control group at 1-month follow-up. For pain free days, the nonparametric test did not detect the between group differences. 71 and 72% of the treatment group achieved clinically significant improvement at the 1- and 3-month follow-ups, respectively, whereas only 19 and 14% of the control group achieved the criterionPedsQL: NS1 and 3 months21.3%[@bb0200]Primary outcome: PCS\
\
Secondary outcomes:\
CPVI, VAS for pain, fatigue and sleep disturbance, FIQ, SF-8, CPAQ, GHQ, feasibility of the smartphone intervention was assessed with single questions post-intervention.FIQVAS- pain level: NSInteractions effects were found on: PCS (ITT); PCS (per protocol); CPAQ; SF8-mental and CPVI.5 months.\
1 year follow-up ([@bb0205])17.0%[@bb0250]Primary outcomes: CALI, pain intensity-NRS, RCADs\
\
Secondary outcomes: MDD, ARCS, TEISFInteraction effects were found on: CALI-prospective scale (online) and CALI-prospective scale (retrospective)An interaction effect was found on pain intensity.\
Retrospective ratings of pain: NS. The mean percent pain reduction in the treatment group was 33.2%. The rate of clinically significant improvement in pain intensity was greater in children in the treatment group for the ITT-sample (38.5% vs 13.6%).RCADS (emotional functioning): NS ARCS (parental responses): NS3 months8.4%[@bb0270]No primary outcome defined.\
Outcome measures:\
CES-D, Depression anxiety stress scales, test of pain knowledge that assessed a wide range of topics addressed within the program, PCP-S, PCP-EA.Pain interference in 10 areas of daily functioning (social, sex, sleep, recreation, household chores, work, self-care, parenting, physical activities, and exercise.Significant interaction effects on pain severityInteraction effects were found on the scales: CES- depression; DASS-stress: DASS-anxiety: DASS-depression; emotional burden and PCP-EA catastrophizing subscale.No FU7.6%[@bb0275]No primary outcome defined.\
\
Outcome measures: Headache and medication index, BDI, HDI.HDI: NSInteraction effects were found on the Headache index; frequency of headache days and Peak intensity. Among the participants in the treatment condition, 50% showed a clinically significant improvementBDI: NSNo FU56%[@bb0280]Primary outcome: MPI-pain interference\
\
Secondary outcomes: PCS, MHC-SF, PDI, HADS, FFMQ, PIPS, Pain-NRSA treatment effect was found on MPI-Interference in favor for ACT comparing to Expressive Writing.\
ACT vs WL: NSSignificant results were found in Pain intensity in favor for ACT comparing to EW.An interaction effect was found on PCS in favor for ACT comparing to WLC.\
An interaction effect was found on PIPS in favor of ACT comparing to EW and to WLC.3 months27.7%[@bb0300]Primary outcomes: BPI, SF-36 Physical Functioning Scale.\
\
Secondary outcomes: MFI; MOS Sleep scale; CES-D, STPI, PGICAn interaction effect was found on SF-36-physical functional scale. The WEB-SM group demonstrated more individual improving 31% vs 6%, NNT 5.\
PGIC: available for only half of the sample (standard care = 33, WEB-SM n = 35) there was a statistically significant difference in the numbers of individuals reporting at least minimal improvement 57% vs 21%).An interaction effect was found on BPI-average pain intensity. Additionally, the proportion of patient reporting a 30% decrease in the mean pain score from baseline to endpoint was significantly greater in the WEB-SM group (29% vs 8%) NNT for the 30% responder rater was 5.MOS-sleep scale: NS\
MFI (fatigue): NS\
CES-Depression: NS\
STPI (anxiety): NSNo FU10.2%[^2]

3.6. Primary outcomes {#s0065}
---------------------

The most frequently measured domain reflected in the primary outcomes was interference/disability (in six of the trials) ([@bb0040], [@bb0125], [@bb0180], [@bb0250], [@bb0280], [@bb0300]), followed by catastrophizing (in five of the studies) ([@bb0055], [@bb0080], [@bb0060], [@bb0120], [@bb0200]). Pain intensity/severity was the primary outcome in four of the trials ([@bb0040], [@bb0180], [@bb0250], [@bb0300]). One study ([@bb0105]) used a survey of pain attitudes (SOPA) as a primary outcome and psychological variables such as depression and anxiety domains were primary outcomes in three trials ([@bb0100], [@bb0125], [@bb0250]). Other included primary outcomes were quality of life ([@bb0175]) and self-efficacy ([@bb0040]).

3.7. Secondary outcomes {#s0070}
-----------------------

Secondary outcomes were reported in 14 of the trials. These outcomes were pain severity, self-efficacy, catastrophizing, fear of movement and re-injury, emotional functioning, disability, acceptance, pain attitudes and beliefs. For more details see [Table 2](#t0010){ref-type="table"}.

3.8. Uncategorized domain and measures {#s0075}
--------------------------------------

Eight ([@bb0020], [@bb0045], [@bb0050], [@bb0110], [@bb0140], [@bb0175], [@bb0270], [@bb0275]) of which five ([@bb0020], [@bb0050], [@bb0140], [@bb0175], [@bb0275]) were headache and/or migraine trials of the 22 studies listed a variety of outcomes but did not specify whether any of these were considered primary or secondary. The domains measured were emotional functioning such as depression and anxiety, pain severity, interference, catastrophizing, pain attitudes and beliefs, headache and medication index and coping strategies.

3.9. Effect of internet-based CBT-based interventions {#s0080}
-----------------------------------------------------

Result across the studies showed a number of beneficial effects. In the present review, effects from the primary analyses are focused. As mentioned earlier several (n = 10) of the included trials included inactive control condition while four used active control groups ([@bb0100], [@bb0080], [@bb0090], [@bb0110]). Two trials ([@bb0175], [@bb0280]) included three conditions and three ([@bb0050], [@bb0270], [@bb0300]) used treatment as usual. Three trials used active treatments, one used internet-based treatment with the addition of telephone support ([@bb0020]), one internet-based treatment without smartphone ([@bb0200]) and the third trial compared the internet-based treatment with face-to-face group intervention ([@bb0120]). For an overview of the results see [Table 2](#t0010){ref-type="table"}.

3.10. Interference and disability {#s0085}
---------------------------------

We calculated effect sizes for the interference/disability measures based on the means and standard deviations at post-treatment. For the studies where the comparison group was either waiting list or treatment as usual the overall random effects effect size in the 15 pain studies was Hedge\'s *g* = − 0.42 (95% CI: − 0.55 to − 0.28), in the direction of favouring treatment but with a significant heterogeneity (*I*^2^ = 53.5%). Publication bias was not present as assessed by Egger\'s test (*p* = .24). Guidance did not moderate this effect (*g* = − 0.39 for guided vs. − 0.37 for unguided treatments). The effect size for the four headache trials was Hedge\'s *g* = − 0.52 (95% CI: − 0.74 to − 0.30), in the direction of favouring treatment and with a non-significant heterogeneity (*I*^2^ = 30.0%). Publication bias was not present from the Egger\'s test (*p* = .07). For the three trials in which internet treatment had been compared against an active control condition (e.g., face-to-face) the results showed an advantage for the comparison condition Hedge\'s *g* = − 0.33 (95% CI: − 0.58 to − 0.008), with no heterogeneity *I*^2^ = 0.0%) or publication bias. A forest plot for the pain and headache studies combined is presented in [Fig. 2](#f0010){ref-type="fig"}. We included the waitlist and treatment as usual control groups (N = 19). Here the effect size was Hedge\'s *g* = − 0.41 (95% CI: − 0.55 to − 0.27), with a significant heterogeneity (*I*^2^ = 50.0%), but no indication of publication bias.Fig. 2Forest plot of studies comparing internet treatment against no treatment or treatment as usual control conditions for pain and headache using pain interference/disability ratings.

3.11. Pain {#s0090}
----------

Effect sizes were calculated for the pain severity measures. For the studies where the comparison group was either waiting list or treatment as usual the overall random effects effect size in 16 pain studies was Hedge\'s *g* = − 0.35 (95% CI: − 0.54 to − 0.17), in the direction of favouring treatment but with a significant heterogeneity (*I*^2^ = 68.6%). Publication bias was not present as assessed by Egger\'s test (*p* = .25). Removing outliers ([@bb0110]) reduced the effect (*g* = − 0.25), but the overall effect remained statistically significant. Guidance did not moderate the effect (with only three studies being unguided). We did not calculate the effect size for the headache studies as there were only two studies in which pain data were provided for the waitlist condition. This was also the case for the active control comparisons with only two trials. The overall effect for pain ratings (both pain and headache compared against waitlist or regular care) involved 18 trials and the effect was Hedge\'s *g* = − 0.38 (95% CI: − 0.56 to − 0.23) in the direction of favouring treatment but with a large significant heterogeneity (*I*^2^ = 67.9%). Publication bias was not present as assessed by Egger\'s test (*p* = .22). A forest plot for the pain and headache studies combined is presented in [Fig. 3](#f0015){ref-type="fig"}.Fig. 3Forest plot of studies comparing internet treatment against no treatment or treatment as usual control conditions for pain and headache using pain severity ratings.

3.12. Catastrophizing {#s0095}
---------------------

We calculated meta-analytic statistics for the catastrophizing outcomes. For the studies where the comparison group was either waiting list of treatment as usual the overall random effects effect size for the 11 pain studies was Hedge\'s *g* = − 0.65 (95% CI: − 0.95 to − 0.36), in the direction of favouring treatment but with a significant heterogeneity (*I*^2^ = 82.2%). Publication bias was not present as assessed by Egger\'s test (*p* = .12). As the [@bb0105] trial had a substantially higher effect size (*g* = − 1.79) we recalculated the effect with this trial removed, which resulted in a lower but still significant effect (*g* = − 0.49). Adding the only controlled headache trial ([@bb0050]) did not change the results (*g* = − 0.70) compared to the overall findings. For an overview for the effects see [Fig. 4](#f0020){ref-type="fig"}.Fig. 4Forest plot of studies comparing internet treatment against no treatment or treatment as usual control conditions for pain and headache using catastrophizing ratings.

3.13. Depression and anxiety {#s0100}
----------------------------

We calculated meta-analytic statistics for the mood ratings (mainly depression). For the 14 pain studies the effect size when comparing against waitlist/treatment as usual was Hedge\'s *g* = − 0.27 (95% CI: − 0.38 to − 0.16), in the direction of favouring treatment and without significant heterogeneity (*I*^2^ = 7.9%). Publication bias was not present as assessed by Egger\'s test (*p* = .10). Adding the three headache trials did not change the result (Hedge\'s *g* = − 0.26). See [Fig. 5](#f0025){ref-type="fig"} for forest plot.Fig. 5Forest plot of studies comparing internet treatment against no treatment or treatment as usual control conditions for pain and headache using depression ratings.

3.14. Risk of bias within studies {#s0105}
---------------------------------

Assessment of the studies was made using an adapted Cochrane Collaboration tool for the risk of bias within randomized trials ([@bb0185]). Five areas of potential bias were assessed: selection bias, detection bias, attrition bias, reporting bias and other bias. Selection bias focus is on the description on the method used to generate the allocation sequence. To assess detection bias description of all used measures was observed and whether there was an intended blinding. Authors need to describe the completeness of outcome data for each main outcome, including attrition and exclusions from the analysis for a low attrition bias. Reporting bias concerns the reporting of the prespecified outcomes. Other bias assesses if any important concerns about bias, not covered in the other domains in the tool are present. An overall assessment of bias was made, where a low overall assessment required low assessments in all the five areas. [Table 3](#t0015){ref-type="table"} provides a summary of the risk of bias assessment. More than half (n = 14) of the trials reported sufficient descriptions of participant randomization, which leads to comparable groups. In eight of the studies, selection bias was unclear since the method of randomization was not described in sufficient detail ([@bb0020], [@bb0105], [@bb0110], [@bb0125], [@bb0140], [@bb0180], [@bb0270], [@bb0275]). Five of the trials did not clearly demonstrate how data was collected ([@bb0045], [@bb0110], [@bb0180], [@bb0200], [@bb0275]). In the remaining trials (n = 17) it was reported that data was collected online and blinded for the researchers. Most trials (n = 17) reported adequate information about attrition. However, four studies ([@bb0045], [@bb0105], [@bb0110], [@bb0180]) did not report attrition clearly enough or no reasons for participants withdrawing were given. Reporting bias was found low in most trials (n = 16) since the pre-specified outcomes were reported. Three trials ([@bb0050], [@bb0105], [@bb0275]) were assessed high risk of reporting bias since not all outcome measures were made available for analyses. In one study ([@bb0275]) one outcome variable was not included in the analyses. In three trials ([@bb0020], [@bb0045], [@bb0140]) reporting bias was judged unclear since no intention-to-treat analyses were made. Overall ten trials ([@bb0040], [@bb0100], [@bb0080], [@bb0090], [@bb0060], [@bb0055], [@bb0120], [@bb0175], [@bb0250], [@bb0280]) were assessed having a low risk of bias and the remaining 12 were judged having unclear risk of bias.Table 3Risk of bias within studies.ReferenceSelection biasSelection bias argumentDetection biasDetections bias argumentAttrition biasAttrition bias argumentReporting biasReporting bias argumentOther biasOther bias argumentOverall assessment of bias[@bb0020]UnclearRandomization method unclearLowAll outcomes are described and administered onlineLowAttrition is well described and analyses between completers and non-completers are made.UnclearNo ITT-analyses.LowStudy appears to be free of other sources of biasUnclear[@bb0040]LowParticipants were randomly assigned to either the intervention or WLC via a simple coin toss.LowAssessments described and taken onlineLowImputed score for standardized scales that were missing no less than 10% of the responses, with the exception of the CES-D 10.LowAll results are reportedLowStudy appears to be free of other sources of bias.Low[@bb0045]LowLottery draw by a study leader who was blindfolded.UnclearOutcomes are scarcely described and are administered both by regular mail and e-mail.UnclearAttrition is explained. Unclear drop-out analyses.UnclearOutcomes are presented. No ITT analyses.LowStudy appears to be free of other sources of biasUnclear[@bb0050]LowRandom number table was used for group assignmentLowAll outcomes are described and administered onlineHighOne outcome measure was not available for analysis.HighAll outcomes are not included, due to a data management error.LowStudy appears to be free of other sources of bias.Unclear risk[@bb0080]LowRandomization was made by an independent person through a randomization page using at true random number service.LowAll outcomes are described and administered onlineLowAttrition is well explained and drop-out analyses were made.LowAll data presented using ITT analyses.LowStudy appears to be free of other sources of bias.Low[@bb0090]LowRandomization was made through a randomization page using at true random number service.LowAll outcomes are described and administered onlineLowAttrition is explained and drop-out analyses were made.LowAll data presented using ITT analyses.LowStudy appears to be free of other sources of bias.Low[@bb0100]LowRandomization was made through a randomization page using at true random number service.LowAll outcomes are described and administered onlineLowAttrition is explained and drop-out analyses were made.LowAll data presented using ITT analyses.LowStudy appears to be free of other sources of bias.Low[@bb0055]LowRandomization was done with a diceLowAll outcomes are described and administered onlineLowAttrition well described. Differences between completers and non-completers are reported.LowAll outcomes are reported and missing data is imputed.LowStudy seems to be free of other sources of biasLow[@bb0060]LowRandomization was made by an independent person through a randomization page.LowAll outcomes are described and administered onlineLowAttrition described and analyses of completer and non-completers was made.LowAll outcome measures were presented according the ITT principle.LowStudy seems to be free of other sources of biasLow[@bb0105]UnclearEligibility criteria changed during allocation (age). Randomization through random number table. No more information given.LowAll measures described, participants and administered onlineUnclearNo information about why participants dropped out.HighNo ITT-data presentedLowStudy appears to be free of other sources of bias.Unclear[@bb0110]\
USAUnclearParticipants were randomized using an adaptive or "stratified" randomization that ensures group equivalence on preselected variables that may relate to outcome across conditions. The method is not described.\
No information about allocation concealment insufficient.UnclearNo information about how the outcomes were administered.UnclearAttrition was described but difference between completers and non-completers is missing.LowAll pre-specified outcomes were presentedLowStudy appears to be free of other sources of bias.Unclear[@bb0120]LowPermuted block randomization (ration 1:1; block size of 14). For allocation sequence was concealed from the researcher enrolling and assessing participants in sequential numbered sealed envelopes.LowAll measures described, participants unidentified.LowAttrition was adequately explained and missing data appeared to have been imputed using appropriate methods.LowPublished report includes data for all expected outcomesLowStudy appears to be free of other sources of bias.Low[@bb0125]UnclearRandomization via a permuted randomization process. No information of method. Groups differed in the PRSS.LowAll measures described, participants unidentifiedLowCompleters described. Attrition described.\
ITT (LCOF)LowAll pre-specified outcomes were presentedLowStudy appears to be free of other sources of bias.Unclear[@bb0140]Unclear riskRandomization method unclearLowAll outcomes are described and administered onlineLowAttrition is well described and dropout predictors are reportedUnclearAll post-data is reported however is not all FU data reported.LowStudy appears to be free of other sources of biasUnclear risk[@bb0175]\
SwedenLowRandomization procedure: a sequence of random numbers was generated in statistical package for the social sciences 18.0 (SPSS) software, stratified by gender. Based on magnitude these numbers were arranged into three equal-sized groups, which translated into the three study groups. Blinded randomization.LowOutcomes well described and administered online.LowAttrition well described and analyses of completers and no-completers reported.LowAll data reported. ITT for main variables.LowStudy appears to be free of other sources of biasLow[@bb0180]Unclear riskRandomization method unclearUnclear riskOutcomes were mailed out but unclear how participants sent their responses.UnclearITT analyses were conducted. No information about why participants dropped out.LowAll expected data is reportedLowStudy appears to be free of other sources of bias.Unclear risk[@bb0200]\
NorwayLowA computer generated sequence list with the 2 groups randomized in blocks of 4 used for practical reasons to ensure similar numbers in each group at each time point.Unclear riskQuestionnaires were administered in paper. No description given if outcome assessors were blinded. Outcomes described.LowAttrition is described and differences between completers and non-completers are reported.LowPublished report includes data for all expected outcomes. ITT analyses.LowStudy appears to be free of other sources of biasUnclear[@bb0250]LowFixed allocation randomization scheme was used. Blocked randomization with blocks of 10. An online random number generator was used. Comparable groupsLowAll measures described, participants unidentified.LowCompleters described. Attrition described.\
ITTLowAll pre-specified outcomes were presentedLowStudy appears to be free of other sources of bias.Low[@bb0270]Unclear riskRandomization method unclearLowAll outcomes are described and administered onlineLowAttrition was adequately explained and missing data appeared to have been imputed using appropriate methods.LowAll prespecified outcomes were presentedLowStudy appears to be free of other sources of biasUnclear[@bb0275]UnclearRandomization method unclearUnclear riskSome outcomes administered online while other on paper. Unclear if blinding was possible. All outcomes described.LowAttrition described and differences between completers and non-completers reported.HighMLPC not reported in the results. No ITT analyses.LowStudy appears to be free of other sources of biasUnclear[@bb0280]LowAllocation to conditions was performed by sequential block wise randomization using an electronically written key, with stratification on gender, age, and educational level.LowAll measures described, participants unidentifiedLowCompleters described. Attrition described.\
ITTLowAll outcomes were presented. ITT mixed model.LowStudy appears to be free of other sources of bias.Low[@bb0300]\
USALowRandomization used 1:1 ratio. A computerized randomization program assisted in the development of the allocation sequence for study. Allocation concealment was utilized to prevent selection bias.LowAll outcomes adequately described and taken online.UnclearAttrition is described but differences between completers and non-completers is not reportedLowPublished report includes data for all expected outcomes\
ITT analyses.LowStudy appears to be free of other sources of biasUnclear

3.15. Attrition {#s0110}
---------------

Drop-out rates in internet-based trials vary significantly. In a review they were reported to range from 2 to 83% ([@bb0245]). A common approach classifies drop-out based on non-completion of one or more assessment or treatment components (i.e. pre-treatment assessments, treatment sessions, post-treatment assessments) ([@bb0245]). The drop-out rates ranged from 4% ([@bb0125]) to 56 % ([@bb0275]). It seems that attrition is a bigger problem in unguided internet-based treatments than guided ones ([@bb0030]). However, in the present review this difference is not clear. In the present review the majority of the trials were guided (72 %). The five unguided trials have drop-out rates that range from 7.1% to 16.4%. The three studies with highest drop-out rates were headache trials and they reported values of 31.9% ([@bb0020]), 38.1 % ([@bb0140]) and 56% ([@bb0275]). For more information see [Table 2](#t0010){ref-type="table"}.

Different trials have used different methods to prevent high drop-out numbers. Several trials used telephone support ([@bb0020], [@bb0080], [@bb0055], [@bb0125], [@bb0175], [@bb0180]). [@bb0020] did not find evidence of an effect of the telephone calls regarding the drop-out rate. All guided trials used personalized reminders and feedback instead of impersonal automatic reminders with the exception of one guided study ([@bb0125]) that employed regular automatic e-mails that reinforced the participants. Several trials also included some live meetings ([@bb0040], [@bb0045], [@bb0175], [@bb0200]). In five trials, participants were paid for completing assessments ([@bb0040], [@bb0050], [@bb0105], [@bb0110], [@bb0270]). The financial incentive varied from a total sum of \$75--\$200. Participants received a financial benefit per measurement point except in one trial ([@bb0040]) where participants received \$100 for their participation in the study project. Four of these trials were unguided ([@bb0050], [@bb0105], [@bb0110], [@bb0270]).

3.16. Software {#s0115}
--------------

The trials included in this review report different security levels to the websites. Four trials ([@bb0100], [@bb0090], [@bb0080], [@bb0280]) describe secure websites that require double identification and all communication takes place on enclosed secure websites. Two unguided studies ([@bb0105], [@bb0300]) report using secure servers with unique user-id. Most trials used user-name and password to log in to the websites and communication took place through e-mails ([@bb0020], [@bb0040], [@bb0045], [@bb0050], [@bb0055], [@bb0060], [@bb0110], [@bb0120], [@bb0140], [@bb0200], [@bb0250], [@bb0275]). Two trials ([@bb0125], [@bb0270]) lacked information regarding inlog to the internet-based treatments. One trial ([@bb0200]) used smartphones as the main source to the treatment in addition to a website; information about the security of the inlog is scarce.

3.17. Time spent on the participants {#s0120}
------------------------------------

Several of the guided trials reported time spent on the participants. [@bb0275] described that the sum of time that the therapist spent per participant was 40 min. Furthermore, a cost-efficient analysis was conducted and the authors conclude that their treatment is as cost-efficient as minimal therapist contact treatment and 12 times as cost-efficient as traditional clinical treatment. In the trial by [@bb0120] a cost-effectiveness analysis was made and showed that in the internet course the costs were €199 lower compared to the group course however, no information of times spent on participants was reported. [@bb0250] reported that 30 min per participant was spent; [@bb0125] described that the total time spent per participant on average was 81.54 min (sd = 30.91) and [@bb0180] reported that the mean time spent was 189 min (telephone calls constituted the majority of the contact time). One trial ([@bb0140]) estimated the time to be 78 min per participant. [@bb0020] described the time the telephone calls lasted, 5--20 min (mean time 10 min) per call of a total of 6 calls. However, no information about the time spent on the internet group without telephone calls is given. Several trials (n = 10) did not report the time spent on the participants ([@bb0040], [@bb0045], [@bb0100], [@bb0090], [@bb0055], [@bb0080], [@bb0060], [@bb0175], [@bb0200], [@bb0280]).

4. Discussion {#s0125}
=============

This review included 22 randomized controlled trials of which two included children/youth and five included individuals with chronic headache and/or migraine. Overall, the literature on internet treatments for pain and headache is heterogeneous and the effects (as assessed by meta-analysis) are small to moderate. The results of this review are thus in line with previous reviews with small to moderate overall effects. However, the present review had broader inclusion of studies including trials on headache and children/youth. The most frequent primary outcome was interference/disability followed by catastrophizing. In the five trials including chronic headache and/or migraine no primary outcomes were defined. Several of the included trials had small sample sizes and reported power issues ([@bb0020], [@bb0045], [@bb0100], [@bb0055], [@bb0060], [@bb0125], [@bb0180], [@bb0250], [@bb0275]). Many studies (n = 12) were assessed as having an unclear level of risk bias. The main focus in the present review was interference/disability and pain but there was also an interest in the measures of catastrophizing, and depression/anxiety.

Most trials (91%) included measures of interference or disability. The majority (n = 12) reported significant results in favor of the internet-based treatment of which two ([@bb0020], [@bb0140]) included individuals with headache. Effect sizes ranged from small to large and a couple ([@bb0020], [@bb0300]) of the trials showed clinical significant effects. However, the overall effect was small (Hedge\'s *g* = − 0.39). Only one trial did not report pain intensity or pain frequency ([@bb0050]). Twelve trials reported significant results on pain intensity and/or pain frequency of which four (of five headache trials) included chronic headache and/or migraine and two paediatric pain. The effect sizes ranged from small to medium, even if not all trials reported effect sizes. When we calculated effect sizes we found a small average effect (Hedge\'s *g* = − 0.33). Thus, for both pain interference/disability and pain severity effects are modest which is in line with the effects of CBT in face-to-face trials ([@bb0145]).

Catastrophizing has been found to be important to target in the treatment of chronic pain since it is associated with several negative consequences in a person\'s life such as psychosocial dysfunction and greater health care utilization ([@bb0215], [@bb0290]). The findings of the present review show that catastrophizing is a common measure since the majority of the trials (n = 14) included some catastrophizing scale. Among the trials that did not measure catastrophizing three included participants with chronic headache and/or migraine and one included paediatric pain. Significant reductions in catastrophizing were found in 13 trials of the 14 studies with effect sizes ranging from small to large. When we calculated meta-analytic statistics the average effect was moderate (Hedge\'s *g* = − 0.65), and somewhat lower when one outlier was removed (*g* = − 0.49). Thus, we conclude that internet-based CBT has the potential to reduce catastrophizing even if larger studies are needed and the effects are moderate.

Emotional distress in terms of depression and anxiety was included in 90% (n = 20) of the trials and significant results were found in the depression scales in favour of the internet-based treatments in 11 studies. Effect sizes range from small to moderate in the six trials that reported effect sizes. Six studies reported significant results in anxiety scales with modest effect sizes. Two of the included trials that showed significant results in both depression and anxiety ([@bb0100], [@bb0125]) used these scales as primary outcomes since the interventions targeted emotional distress in chronic pain adults. The effect size we calculated was small (Hedge\'s *g* = − 0.26), leaving much room for improvement.

Attrition can be a big problem in internet-based treatments and it is therefore important to engage and involve the user in the treatment which can motivate the person to learn and progress through the program ([@bb0010]). A recent systematic review concluded that although guidance is a beneficial feature of internet-based interventions, its effect is smaller than reported before when compared to unguided interventions ([@bb0030]). Interestingly the difference in attrition in the present review was not obvious between the guided and unguided trials as proposed by research ([@bb0030]). However, the majority of the included trials (n = 17) were guided. The range in attrition levels was considerable, from 4% to 54%. The studies with highest drop-out levels were the chronic headache trials with drop-out rates between 31.9%--56%. Since, drop-out is a common problem in internet-based intervention different methods were used to prevent this problem such as telephone support, personalized reminders and feedback, and financial incitements. It is unclear how much these methods were helpful.

There are limitations that need to be mentioned. First, we need to acknowledge the fact that we reviewed a broad range of studies, which is reflected in a wide variety of outcomes, different treatment formats, lengths of treatment and many other aspects. Pain is a broad construct and it is possible that we may have missed studies and the decision not to include related problems such as irritable bowel syndrome is a potential limitation as well. Second, as we do not have enough studies yet it is hard to conduct moderator analyses to discern what works ([@bb0025]). For example, we had very few studies on unguided internet-based CBT treatments which are common forms of treatment but usually not as effective as guided treatments. Furthermore, the quality of the trials could have been better and there is a need for better trials with larger samples that are described in more detail. For example, it can be hard to grasp how the intervention looks like without screenshots that are rarely available for the reader of a paper. Given the public health implications of chronic pain conditions (including headache) it is crucial that new treatments and formats (e.g., internet delivery) are carefully investigated and described before they are disseminated. As a third limitation, we acknowledge the fact that most of the studies we reviewed are not conducted in clinical regular settings which calls for studies that are more representative for regular health care settings (so-called effectiveness studies). Fourth, as mentioned earlier more than half of the included trials had an overall unclear risk of bias. However, to be assessed as low risk of bias all five criteria needed to be rated as low risk. Fifth, few of the included studies conducted a proper cost-effectiveness analysis. Future studies should include this kind of data. Another important topic to investigate is the possibility of negative and harmful effects ([@bb0265]). Furthermore, it is important to compare the internet-based interventions with credible alternative treatments. The majority of the included trial in the present review used wait-list controls, which can be justified when there is no alternative treatment available but still leaves the question of how the treatment works against alternative treatments. It is difficult to conclude regarding the results in the headache and/or migraine trials; more studies are needed. One trial ([@bb0200]) in the present review included smartphone communication for women with widespread pain. Probably, smartphones and apps will increase as complements or as a sole intervention in the area of self-help. A recent systematic review ([@bb0295]) showed that most of the pain-related apps included in their review not only lacked evidence of health care professionals input regarding development but also contained few evidence-based pain management features. There is room for improvement in this area.

There are however, also some strengths to consider. Internet offers several advantages: reducing costs and increasing convenience for users, reducing health service costs, and reaching isolated groups, furthermore it can offer a treatment opportunity avoiding stigmatization and persons have often timeless access to internet and thereby to the treatment. For being a fairly recent format for delivery of pain treatment there are many controlled trials and at the very least the findings are promising. In addition, the findings of the included trials are comparable with the effects of CBT in general for chronic pain ([@bb0145]). Hopefully, new trials will help us improve the outcomes and better tailor interventions to the needs of the patients.

[^1]: CBT = cognitive behavior therapy, ACT = acceptance and commitment therapy.

[^2]: NS = no significance; SOPA = The Survey of Pain Attitudes; FABQ = Fear Avoidance Beliefs Questionnaire, PCS = Pain Catastrophizing Scale, NMRS = Negative Mood Regulation Scale, RMDQ = Roland-Morris Disability Questionnaire, SES = Pain self-efficacy Scale, PDI = Pain Disability Index, MPI = Multidimensional Pain Inventory, HADS = Hospital Anxiety Depression Scale, FFMQ = Five Facet Mindfulness Questionnaire, PIPS = Psychological Inflexibility in Pain Scale, ELS = Engaged Living Scale, MHC-SF = Mental Health Continuum-Short Form, PHQ-9 = Patient Health Questionnaire 9-item, GAD-7 = Generalized Anxiety Disorders 7-item, WBQ = Wisconsin Brief Pain Questionnaire, PSEQ = Pain Self-efficacy Questionnaire, TSK = TAMPA Scale of Kinesiophobia, PRSS = Pain Responses Self-Statements, CALI = Child Activity Limitations Interview, Pain NRS = Numerical Rating Scale, RCADS = Revised Child Anxiety Depression Scale, ARCS = Adult Responses to Children\'s Symptoms, TEISF = Treatment Evaluation Inventory-Short Form, CSQ = The Coping Strategies Questionnaire, PAIRS = Pain Impairment Relationship Scale, QOLI = Quality of Life Inventory, CPAQ = Chronic Pain Acceptance Questionnaire, MADRS-S = Montgomery--Åsberg Depression Rating Scale-Swedish version, BAI = Beck Anxiety Inventory, ASI = Anxiety Sensitivity Index, BPI = Brief Pain Inventory-Short Form, PSEQ = Pain Self-efficacy Questionnaire, CES-D = Center Epidemiologic studies Short Depression Scale, STAI-6 = State--Trait Anxiety Inventory, MIDAS = Migraine disability assessment questionnaire, CPCI-42 = Chronic Pain Coping Inventory-42, HSES = Headache management self-efficay scale, DASS-21 = Depression Anxiety Stress Scales, PGIC = Patient Global Impression of Change, ODQ = Oswestry Disability Questionnaire, HDI = Headache Disability Inventory, HSQ = Headache Symptom Questionnaire, PQ23 = Quality of life questionnaire, BDI = Beck depression inventory, PSS = The Perceived Stress Scale, PCP-S = Profile of Chronic Pain-Screen, PCP-EA = Profile of Chronic Pain Extended Assessment, SF-36 = SF-36 Physical Functioning Scale, MFI = Multidimensional Fatigue Inventory, STPI = State--Trait Personality Inventory, SF-36 = Medical Outcomes 36-Item Short-Form Health Survey, CPVI = The Chronic Pain Values Inventory, VAS = Visual analog scales, FIQ = Fibromyalgia Impact Questionnaire, SF-8 = Short form health survey, GHQ = General Health Questionnaire, PedsQL = Pediatric Quality of Life Inventory, PCCL = Pain Coping and Cognition List, RAND36 = Global health-related quality of life.
